Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study

被引:29
作者
Wang, Weiqi [1 ]
Bhole, Vidula Manish [2 ]
Krishnan, Eswar [1 ]
机构
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] EpiSolut Consultancy Serv, Thana, Maharashtra, India
来源
BMJ OPEN | 2015年 / 5卷 / 04期
关键词
CARDIOVASCULAR-DISEASE; SERUM URATE; HYPERURICEMIA; MORTALITY;
D O I
10.1136/bmjopen-2014-006843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Historically, the nature of association between chronic kidney disease (CKD) and gouty arthritis has been unclear. The goal of the present study was to test the hypothesis that CKD is an independent risk factor for developing incident gout. Design: Patients were from the original Framingham Heart Study cohort. Using Cox proportional hazard models we estimated the HR of CKD to incident gout among men and women separately after adjusting for age, alcohol consumption, smoking, hypertension, diabetes and body mass index. Settings: Patients were all from Framingham, Massachusetts, USA. Participants: Excluding patients who had CKD in the first visit from this study, 2159 men and 2558 women were selected covering a 54-year period (1948-2002). Results: There were 371 incident cases (231 men and 140 women) of gout over the follow-up of 140 421 person-years. Incidence rates of gout per 1000 person-years for participants with and without CKD were 6.82 (95% CI 5.10 to 9.10) and 2.43 (2.18 to 2.71), respectively. In multivariable Cox models, CKD was associated with gout, with a HR of 1.88 (1.13 to 3.13) among men and 2.31 (1.25 to 4.24) among women. Additional analyses using alternate definitions for CKD and cross-sectional study did not change the results. Sensitivity analysis suggested that the observed findings might be an underestimate of the true relative risk. Conclusions: The present study provides epidemiological evidence to support the notion that CKD is a risk factor for gout.
引用
收藏
页数:6
相关论文
共 28 条
  • [1] GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    BRAND, FN
    KANNEL, WB
    CASTELLI, WP
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) : 237 - 242
  • [2] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413
  • [3] Hyperuricaemia - Where nephrology meets rheumatology
    Avram, Z.
    Krishnan, E.
    [J]. RHEUMATOLOGY, 2008, 47 (07) : 960 - 964
  • [4] Clive DM, 2000, J AM SOC NEPHROL, V11, P974, DOI 10.1681/ASN.V115974
  • [5] DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279
  • [6] Edwards N Lawrence, 2008, Cleve Clin J Med, V75 Suppl 5, pS13
  • [7] Glycemic status and development of kidney disease - The Framingham Heart Study
    Fox, CS
    Larson, MG
    Leip, EP
    Meigs, JB
    Wilson, PWF
    Levy, D
    [J]. DIABETES CARE, 2005, 28 (10) : 2436 - 2440
  • [8] Chronic kidney disease in gout in a managed care setting
    Fuldeore, Mahesh J.
    Riedel, Aylin A.
    Zarotsky, Victoria
    Pandya, Bhavik J.
    Dabbous, Omar
    Krishnan, Eswar
    [J]. BMC NEPHROLOGY, 2011, 12
  • [9] Basic methods for sensitivity analysis of biases
    Greenland, S
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (06) : 1107 - 1116
  • [10] Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010
    Juraschek, Stephen P.
    Kovell, Lara C.
    Miller, Edgar R., III
    Gelber, Allan C.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 42 (06) : 551 - 561